Drugs & Targets FDA approves Elahere for FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer March 29, 2024Vol.50 No.13
Drugs & Targets FDA grants orphan drug designation to Heidelberg Pharma agent for MM March 29, 2024Vol.50 No.13
Regulatory News ODAC votes in favor of two CAR T-cell therapies for MM after weighing FDA concerns about early deaths March 22, 2024Vol.50 No.12By Jacquelyn Cobb and Paul Goldberg
NCI Rathmell announces new cancer screening network, new NCI virtual clinical trials office March 22, 2024Vol.50 No.12By Matthew Bin Han Ong
U.S., Sweden sign cancer research and innovation pact as part of preparedness plan for potential Russian aggression March 22, 2024Vol.50 No.12By Matthew Bin Han Ong
In Brief ASCO 2024 special awards go to: Winn, Bhatia, Dale, Siu, Pierce, Kantoff, Newman, Gopal, Mutebi, Feldman, Gorlick, Pietenpol, Abrahm, Giordano, Vaz-Luis March 22, 2024Vol.50 No.12
In Brief Brian Druker named OHSU Knight CEO; Tom Sellers named cancer center director March 22, 2024Vol.50 No.12
In Brief Melissa Bondy receives ASPO’s Joseph F. Fraumeni, Jr., Distinguished Achievement Award March 22, 2024Vol.50 No.12
In Brief Matthew Carpenter receives ASPO’s Joseph W. Cullen Memorial Award March 22, 2024Vol.50 No.12
In Brief UNM Cancer Center program to encourage interest in STEM to include middle schoolers March 22, 2024Vol.50 No.12
